Vascular Pharmaceuticals Employee Directory

Biotechnology ResearchNorth Carolina, United States0-1 Employees

Vascular Pharmaceuticals is a biotechnology research company based in Chapel Hill, North Carolina. Founded in 2005, it operates as a Delaware C-Corporation focused on developing targeted therapies for diabetic complications, with its lead program targeting a specific site within the αVβ3 receptor to modulate the insulin-like growth factor I signaling pathway. The company is pursuing clinical development of a humanized monoclonal antibody that, in preclinical models, showed improvements in renal pathology relevant to diabetic nephropathy, including normalization of proteinuria-related markers.

Vascular Pharmaceuticals positions itself within the biotech sector by advancing antibody-based therapies aimed at kidney-related outcomes in diabetes. Its work involves advancing a clinical program through Phase 2 trials, with a model that ties its development trajectory to strategic consideration of potential acquisition terms after key trial milestones. The company has collaborated with academic IP licensed from UNC-Chapel Hill and has engaged life science investors for its financing activities, reflecting its positioning as a research-focused enterprise pursuing translational opportunities in diabetic kidney disease.

Sign up for free to view info

Company overview Email format